Key Finding
Acupuncture and moxibustion show promise for reducing inflammation and improving IBD symptoms in preliminary studies, but current clinical trial quality is insufficient to recommend them as alternative therapy, though they may serve as safe complementary approaches.
Researchers reviewed the existing evidence on complementary and alternative medicine (CAM) approaches for inflammatory bowel disease (IBD), focusing on massage, acupuncture, and moxibustion therapy. IBD includes conditions like Crohn's disease and ulcerative colitis, which cause chronic inflammation in the digestive tract. Many people with IBD turn to complementary therapies alongside their conventional treatments, with massage, acupuncture, and moxibustion being among the most popular choices.
The study found that massage therapy has not been well-researched in IBD patients, so scientists cannot yet say whether it provides meaningful benefits. However, acupuncture and moxibustion showed more promising results. Research in both animals and humans suggests these therapies may help reduce inflammation and improve IBD symptoms. Moxibustion involves burning dried mugwort herb near specific points on the body to produce therapeutic heat.
Despite these encouraging findings, the researchers noted that the quality of current clinical trials is not strong enough to recommend acupuncture or moxibustion as standalone alternatives to conventional IBD treatment. The studies conducted so far have limitations in their design or execution that make it difficult to draw definitive conclusions.
What this means for you: If you have IBD and are interested in acupuncture or moxibustion, these therapies appear to be generally safe and may offer benefits when used alongside your regular medical treatment. They should not replace conventional IBD medications but could serve as complementary approaches to help manage your symptoms. The safety profile is reassuring, though more high-quality research is needed to fully understand their effectiveness. If you decide to try acupuncture or moxibustion, seek treatment from a licensed, qualified practitioner experienced in working with digestive conditions.
This review examined complementary and alternative medicine (CAM) use in inflammatory bowel disease (IBD), with emphasis on massage, acupuncture, and moxibustion. Evidence for massage therapy in IBD populations remains insufficient to determine therapeutic benefit. Acupuncture and moxibustion demonstrated anti-inflammatory effects and symptomatic improvement in both animal models and human studies. However, methodological limitations in existing clinical trials preclude definitive recommendations for these modalities as alternative treatment options. Study quality concerns include inadequate sample sizes, lack of appropriate controls, and insufficient standardization of treatment protocols. The safety profile for acupuncture and moxibustion appears favorable with minimal adverse events reported. Clinical takeaway: While current evidence does not support acupuncture or moxibustion as standalone IBD therapy, their safety profile and preliminary efficacy data suggest potential value as adjunctive treatment to conventional pharmacological management. Clinicians may consider discussing these options with patients seeking integrative approaches, emphasizing their complementary rather than alternative role in IBD care.
Browse our directory of verified licensed practitioners near you.
Find a practitioner โ๐ IBS patients exhibit significantly reduced intestinal microbiome diversity and distinct phylum-level dysbiosis patterns, with IBS-D showing decreased Butyricimonas and Proteobacteria while IBS-C demonstrates reduced Firmicutes and Actinobacteria.
๐ Chronic gut inflammation and microbial dysbiosis in IBS significantly exacerbate atopic dermatitis symptoms, with fecal microbial transplantation from IBS subjects reproducing this effect, confirming the gut-skin axis mechanism.
๐ Acupuncture and moxibustion at ST 36 significantly improved IBS-D symptoms by restoring gut microbiota diversity, increasing beneficial bacteria like Bifidobacterium, and reducing inflammatory lipopolysaccharide biosynthesis.